Cargando…
Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control
Nitric oxide (NO) holds great promise as a treatment for cancer hypoxia, if its concentration and localization can be precisely controlled. Here, we report a “Trojan Horse” strategy to provide the necessary spatial, temporal, and dosage control of such drug-delivery therapies at targeted tissues. De...
Autores principales: | Evans, Michael A., Huang, Po-Ju, Iwamoto, Yuji, Ibsen, Kelly N., Chan, Emory M., Hitomi, Yutaka, Ford, Peter C., Mitragotri, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939611/ https://www.ncbi.nlm.nih.gov/pubmed/29780505 http://dx.doi.org/10.1039/c8sc00015h |
Ejemplares similares
-
Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide
por: Zhou, Hui-fang, et al.
Publicado: (2014) -
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
por: Wu, Debra, et al.
Publicado: (2021) -
Macrophages Recognize Size and Shape of Their Targets
por: Doshi, Nishit, et al.
Publicado: (2010) -
The Roles of Macrophages and Nitric Oxide in Interleukin-3-Enhanced HSV-Sr39tk-Mediated Prodrug Therapy
por: Yu, Ching-Fang, et al.
Publicado: (2013) -
Ionic liquids for addressing unmet needs in healthcare
por: Agatemor, Christian, et al.
Publicado: (2018)